avatrombo相关论文
avatrombopag是第2代口服生物可利用小分子血小板生成素受体激动剂,可以模拟血小板生成素的作用,增加血小板的产生。2018年5月FDA......
Thrombocytopenia is a multifactorial disorder that is common in patients with chronic liver disease(CLD),leading to chal......